J&J the big daddy of all Pharma is not waiting any longer to get involved in stem cell therapy
Potentially a $337 million deal with Cardio focused Capricor announced last week.
http://www.genengnews.com/gen-news-...therapy-collaboration-with-capricor/81249320/
No doubt other Big Pharma are watching with an eagle eye on progress with clinical trials and progress with regulators in different jurisdictions, and awaiting the ability to manufacture clinical grade cells at scale with 100% consistency and cost efficiency . So far this has eluded all the big names in USA and even MSB .
However this one looks promising and represents great value with excellent scientific team behind it, wouldn't be surprised to see a Pharma partnership or deal this year.
J&J the big daddy of all Pharma is not waiting any longer to get...
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |